Cellular Biomedicine (CBMG) Stock News
NASDAQ:CBMG - Nasdaq -
CBMG Latest News, Press Relases and Analysis
Cellular Biomedicine Group, Inc. Announces Completion of Merger
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 19) Angion Biomedica Corp (...
Cellular Biomedicine Group, Inc. Stockholders Approve Merger
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X Genomics Inc (NASDAQ:...
Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, WORK, and UROV
NEW YORK, NY / ACCESSWIRE / January 3, 2021 / Lifshitz Law Firm, P.C.: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management. If you are a CBMG investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages HMSY, HCAP, CBMG, and AKER Shareholders to Contact the Firm
NEW YORK, NY / ACCESSWIRE / January 2, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: HMS Holdings Corp. (NASDAQ:HMSY) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Gainwell Technologies for $37.00 in cash per share. If you are an HMS shareholder, click here to learn more about your rights and
ALERT: Halper Sadeh LLP Encourages PNM, NAV, HDS, and CBMG Shareholders to Contact the Firm
NEW YORK, NY / ACCESSWIRE / December 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following mergers: PNM Resources, Inc. (NYSE:PNM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Avangrid, Inc. for $50.30 in cash per share. If you are a PNM shareholder, click here to learn more about your legal rights and
Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual Meeting
GAITHERSBURG, Md. and SHANGHAI, Dec. 4, 2020 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ('CBMG' or the 'Company'), a biopharma...
Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual Meeting
- C-CAR088 Anti-BCMA CAR-T Cell Therapy for Multiple Myeloma (MM)
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, COP, and EIGI
NEW YORK, NY / ACCESSWIRE / December 3, 2020 /Lifshitz Law Firm, P.C.: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management. If you are a CBMG investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, CXO, and EIGI
NEW YORK, NY / ACCESSWIRE / November 24, 2020 / Lifshitz Law Firm, P.C.: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management. If you are a CBMG investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua